Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
ABT | NYSE | USD | Real-time | |
0Q15 | London | USD | Real-time | |
ABT | BIVA | MXN | Delayed | |
ABT | Mexico | MXN | Delayed | |
ABT | Switzerland | CHF | Delayed | |
ABT | Xetra | EUR | Delayed | |
ABT | Frankfurt | EUR | Delayed | |
ABT | TradeGate | EUR | Delayed | |
ABTCL | Santiago | CLP | Delayed | |
ABT | Buenos Aires | ARS | Delayed | |
ABTT34 | B3 | BRL | Delayed | |
ABT | Vienna | EUR | Real-time | |
ABT_KZ | KASE | USD | Delayed |
Abbott Laboratories reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 10,241 million compared to USD 10,091 million a year ago. Net income was USD 1,594 million compared to USD 1,033 million a year ago. Diluted earnings per share from continuing operations was USD 0.91 compared to USD 0.59 a year ago.
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 10241 | 10143 | 9978 | 9747 |
Gross Profit | 5710 | 5538 | 5495 | 5433 |
Operating Income | 2057 | 1769 | 1663 | 1678 |
Net Income | 1594 | 1436 | 1375 | 1318 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 73214 | 72090 | 73354 | 73794 |
Total Liabilities | 34387 | 34396 | 35950 | 36562 |
Total Equity | 38827 | 37694 | 37404 | 37232 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 3038 | 1877 | 1203 | 1143 |
Cash From Investing Activities | -824 | -634 | -1213 | -462 |
Cash From Financing Activities | -2052 | -2340 | -1289 | -1410 |
Net Change in Cash | 187 | -1126 | -1326 | -721 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review